Bristol-Meyers Says Ipilimumab Prolongs Survival in Metastatic Melanoma

This morning health business mavens are chirping with bright results for ipilimumab, a monoclonal antibody that can extend life in people with metastatic melanoma. If the new data – which I haven’t seen – are true, it’s good news for patients. In 2010, melanoma affected 68,000 people in the U.S. and led to death in […]

Posted in cancer treatment, clinical trials, Medical News, Oncology (cancer)Tagged , , , , , , Leave a Comment on Bristol-Meyers Says Ipilimumab Prolongs Survival in Metastatic Melanoma

Benlysta, A New Treatment for Lupus

Lupus, an autoimmune disease, turned up on the front page, right side of today’s Wall Street Journal. It cropped up, also, on the first page of the New York Times business section, and elsewhere. Scientific American published a nice on-line review, just now. The reason is that yesterday the FDA approved a new, monoclonal antibody […]

Posted in clinical trials, health care costs, Medical News, Rheumatology, ScienceTagged , , , , , , , , Leave a Comment on Benlysta, A New Treatment for Lupus
newsletter software